Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination

A. Mancini, L. De Marinis, F. Calabrò, R. Sciuto, A. Oradei, S. Lippa, S. Sandric, G. P. Littarru, A. Barbarino

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In previous works we have demonstrated that Coenzyme Q10 (CoQ10) levels have a significant inverse correlation with thyroid hormone concentration in patients with spontaneous hyper- or hypothyroidism. In order to verify whether this correlation is maintained in patients on long-term amiodarone therapy, in whom thyroid metabolism is altered by the iodine contained in the drug, we have studied 30 patients with thyroid dysfunction induced by chronic amiodarone treatment. We have distinguished four groups of patients: group A (n = 8): patients with true hyperthyroidism induced by drug administration; group B (n = 11): patients with mild hyperthyroid symptoms, but isolated thyroxine increase or dissociation between different indexes of thyroid function; group C (n = 5): patients with normal thyroid hormone levels, but increased TSH levels; group D (n = 6): patients who appeared really clinically euthyroid, with normal thyroid hormone levels and normal TSH response to TRH. In group A patients, plasma CoQ10 levels averaged 0.49 ± 0.03 μg/ml, significantly lower than those in normal subjects and similar to those observed in spontaneous hyperthyroid patients. In group B patients, CoQ10 levels were in the normal range (0.88 ± 0.10 μg/ml). In group C patients, CoQ10 levels were lower than those in normal subjects and similar to those of group A patients (0.49 ± 0.04 μg/ml); they differed, in regards to CoQ10 values, in comparison with spontaneous primary hypothyroid patients, who had very high levels of plasma CoQ10. Finally, in group D patients, CoQ10 levels were in the normal range (0.77 ± 0.04 μg/ml). The present investigation demonstrated that, in patients on amiodarone treatment, CoQ10 levels correlated better with metabolic status than with thyroid hormone levels; CoQ10 determination could be useful in discriminating ‘true’ from ‘pseudo’-hyperthyroid conditions, due to a contaminating effect of the iodinerepleted drug amiodarone.

Original languageEnglish
Pages (from-to)511-516
Number of pages6
JournalJournal of Endocrinological Investigation
Volume12
Issue number8
DOIs
Publication statusPublished - 1989

Fingerprint

coenzyme Q10
Amiodarone
Thyroid Gland
Hyperthyroidism
Thyroid Hormones

Keywords

  • amiodarone
  • Coenzyme Q
  • iodine
  • thyroid hormones
  • thyrotropin

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Evaluation of metabolic status in amiodarone-induced thyroid disorders : plasma coenzyme Q10 determination. / Mancini, A.; De Marinis, L.; Calabrò, F.; Sciuto, R.; Oradei, A.; Lippa, S.; Sandric, S.; Littarru, G. P.; Barbarino, A.

In: Journal of Endocrinological Investigation, Vol. 12, No. 8, 1989, p. 511-516.

Research output: Contribution to journalArticle

Mancini, A, De Marinis, L, Calabrò, F, Sciuto, R, Oradei, A, Lippa, S, Sandric, S, Littarru, GP & Barbarino, A 1989, 'Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination', Journal of Endocrinological Investigation, vol. 12, no. 8, pp. 511-516. https://doi.org/10.1007/BF03350748
Mancini, A. ; De Marinis, L. ; Calabrò, F. ; Sciuto, R. ; Oradei, A. ; Lippa, S. ; Sandric, S. ; Littarru, G. P. ; Barbarino, A. / Evaluation of metabolic status in amiodarone-induced thyroid disorders : plasma coenzyme Q10 determination. In: Journal of Endocrinological Investigation. 1989 ; Vol. 12, No. 8. pp. 511-516.
@article{334c4fdb6b194909853979435b71e356,
title = "Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination",
abstract = "In previous works we have demonstrated that Coenzyme Q10 (CoQ10) levels have a significant inverse correlation with thyroid hormone concentration in patients with spontaneous hyper- or hypothyroidism. In order to verify whether this correlation is maintained in patients on long-term amiodarone therapy, in whom thyroid metabolism is altered by the iodine contained in the drug, we have studied 30 patients with thyroid dysfunction induced by chronic amiodarone treatment. We have distinguished four groups of patients: group A (n = 8): patients with true hyperthyroidism induced by drug administration; group B (n = 11): patients with mild hyperthyroid symptoms, but isolated thyroxine increase or dissociation between different indexes of thyroid function; group C (n = 5): patients with normal thyroid hormone levels, but increased TSH levels; group D (n = 6): patients who appeared really clinically euthyroid, with normal thyroid hormone levels and normal TSH response to TRH. In group A patients, plasma CoQ10 levels averaged 0.49 ± 0.03 μg/ml, significantly lower than those in normal subjects and similar to those observed in spontaneous hyperthyroid patients. In group B patients, CoQ10 levels were in the normal range (0.88 ± 0.10 μg/ml). In group C patients, CoQ10 levels were lower than those in normal subjects and similar to those of group A patients (0.49 ± 0.04 μg/ml); they differed, in regards to CoQ10 values, in comparison with spontaneous primary hypothyroid patients, who had very high levels of plasma CoQ10. Finally, in group D patients, CoQ10 levels were in the normal range (0.77 ± 0.04 μg/ml). The present investigation demonstrated that, in patients on amiodarone treatment, CoQ10 levels correlated better with metabolic status than with thyroid hormone levels; CoQ10 determination could be useful in discriminating ‘true’ from ‘pseudo’-hyperthyroid conditions, due to a contaminating effect of the iodinerepleted drug amiodarone.",
keywords = "amiodarone, Coenzyme Q, iodine, thyroid hormones, thyrotropin",
author = "A. Mancini and {De Marinis}, L. and F. Calabr{\`o} and R. Sciuto and A. Oradei and S. Lippa and S. Sandric and Littarru, {G. P.} and A. Barbarino",
year = "1989",
doi = "10.1007/BF03350748",
language = "English",
volume = "12",
pages = "511--516",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "8",

}

TY - JOUR

T1 - Evaluation of metabolic status in amiodarone-induced thyroid disorders

T2 - plasma coenzyme Q10 determination

AU - Mancini, A.

AU - De Marinis, L.

AU - Calabrò, F.

AU - Sciuto, R.

AU - Oradei, A.

AU - Lippa, S.

AU - Sandric, S.

AU - Littarru, G. P.

AU - Barbarino, A.

PY - 1989

Y1 - 1989

N2 - In previous works we have demonstrated that Coenzyme Q10 (CoQ10) levels have a significant inverse correlation with thyroid hormone concentration in patients with spontaneous hyper- or hypothyroidism. In order to verify whether this correlation is maintained in patients on long-term amiodarone therapy, in whom thyroid metabolism is altered by the iodine contained in the drug, we have studied 30 patients with thyroid dysfunction induced by chronic amiodarone treatment. We have distinguished four groups of patients: group A (n = 8): patients with true hyperthyroidism induced by drug administration; group B (n = 11): patients with mild hyperthyroid symptoms, but isolated thyroxine increase or dissociation between different indexes of thyroid function; group C (n = 5): patients with normal thyroid hormone levels, but increased TSH levels; group D (n = 6): patients who appeared really clinically euthyroid, with normal thyroid hormone levels and normal TSH response to TRH. In group A patients, plasma CoQ10 levels averaged 0.49 ± 0.03 μg/ml, significantly lower than those in normal subjects and similar to those observed in spontaneous hyperthyroid patients. In group B patients, CoQ10 levels were in the normal range (0.88 ± 0.10 μg/ml). In group C patients, CoQ10 levels were lower than those in normal subjects and similar to those of group A patients (0.49 ± 0.04 μg/ml); they differed, in regards to CoQ10 values, in comparison with spontaneous primary hypothyroid patients, who had very high levels of plasma CoQ10. Finally, in group D patients, CoQ10 levels were in the normal range (0.77 ± 0.04 μg/ml). The present investigation demonstrated that, in patients on amiodarone treatment, CoQ10 levels correlated better with metabolic status than with thyroid hormone levels; CoQ10 determination could be useful in discriminating ‘true’ from ‘pseudo’-hyperthyroid conditions, due to a contaminating effect of the iodinerepleted drug amiodarone.

AB - In previous works we have demonstrated that Coenzyme Q10 (CoQ10) levels have a significant inverse correlation with thyroid hormone concentration in patients with spontaneous hyper- or hypothyroidism. In order to verify whether this correlation is maintained in patients on long-term amiodarone therapy, in whom thyroid metabolism is altered by the iodine contained in the drug, we have studied 30 patients with thyroid dysfunction induced by chronic amiodarone treatment. We have distinguished four groups of patients: group A (n = 8): patients with true hyperthyroidism induced by drug administration; group B (n = 11): patients with mild hyperthyroid symptoms, but isolated thyroxine increase or dissociation between different indexes of thyroid function; group C (n = 5): patients with normal thyroid hormone levels, but increased TSH levels; group D (n = 6): patients who appeared really clinically euthyroid, with normal thyroid hormone levels and normal TSH response to TRH. In group A patients, plasma CoQ10 levels averaged 0.49 ± 0.03 μg/ml, significantly lower than those in normal subjects and similar to those observed in spontaneous hyperthyroid patients. In group B patients, CoQ10 levels were in the normal range (0.88 ± 0.10 μg/ml). In group C patients, CoQ10 levels were lower than those in normal subjects and similar to those of group A patients (0.49 ± 0.04 μg/ml); they differed, in regards to CoQ10 values, in comparison with spontaneous primary hypothyroid patients, who had very high levels of plasma CoQ10. Finally, in group D patients, CoQ10 levels were in the normal range (0.77 ± 0.04 μg/ml). The present investigation demonstrated that, in patients on amiodarone treatment, CoQ10 levels correlated better with metabolic status than with thyroid hormone levels; CoQ10 determination could be useful in discriminating ‘true’ from ‘pseudo’-hyperthyroid conditions, due to a contaminating effect of the iodinerepleted drug amiodarone.

KW - amiodarone

KW - Coenzyme Q

KW - iodine

KW - thyroid hormones

KW - thyrotropin

UR - http://www.scopus.com/inward/record.url?scp=0024434578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024434578&partnerID=8YFLogxK

U2 - 10.1007/BF03350748

DO - 10.1007/BF03350748

M3 - Article

C2 - 2592737

AN - SCOPUS:0024434578

VL - 12

SP - 511

EP - 516

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 8

ER -